Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitaxsentan versus nifedipine in chronic kidney disease with proteinuria
2006-002004-33Phase 2Completed
- Sponsor
- Encysive Pharmaceuticals Inc.
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sitaxsentan and nifedipine in chronic kidney disease (CKD) (2 arms), sponsored by Encysive Pharmaceuticals Inc. Primary endpoint: Change in proteinuria. Started Sep 2006; status: completed.
02
Drugs
sitaxsentannifedipine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-002004-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002004-33.